ArticleThe Journal of experimental medicine2026

In vivo CRISPR/Cas9 screens identify new regulators of B cell activation and plasma cell differentiation.

Lesly Calderón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.